Year-End Push To Meet FDAAA Puts 14 Advisory Committee Meetings On Tap
This article was originally published in The Tan Sheet
The Center for Drug Evaluation and Research will hold more than twice the typical number of advisory committee meetings in November and December this year - capping off a significant overall increase in panels convened in 2008
You may also be interested in...
FDA advisory committees are increasingly relying on temporary members to fill their ranks - a trend that could result in less predictability for drug sponsors at a make-or-break review meeting
In a podcast interview, Janet Woodcock talks about review deadlines, prioritizing pre-approval inspections, and how advisory committees could be held in an era of social distancing.
Anand Shah returns to FDA as deputy commissioner; like Abernethy, he is an oncologist with a background in big data.